Does peroxisome proliferator-activated receptor gamma agonism modify the effects of growth hormone on lipolysis and insulin sensitivity?
The impact of GH on lipolysis and insulin sensitivity can be modified by administration of TZDs.
Surgical therapy for locoregional esophageal cancer is likely underused. Racial variations in esophagectomy are significant. Referral to specialized centers may result in an increase in patients considered for surgical therapy.